DARZALEX 20 mg/mL concentrate for solution for infusion. | ED Material - HCP | Medicines.ie

Home
Medicines
DARZALEX 20 mg/mL concentrate for solution for infusion.

Company:
Janssen Sciences Ireland (a Johnson & Johnson Company)
Status:
Updated
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Daratumumab
*Additional information is available within the SPC or upon request to the company

Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.

(Click to Download)
Darzalex Patient Card
Risk Minimisation Materials
(Click to Download)
Darzalex (daratumumab) Healtcare Professional Card
Risk Minimisation Materials
(Click to Download)
Darzalex (daratumumab) Card for Haematology/Transfusin Laboratory
Risk Minimisation Materials